Örebro University Hospital is a university hospital in Örebro, Sweden. The hospital is operated by Örebro County Council and took its current name in 2000, having previously been called Örebro Regional Hospital.

There are 462 (2015-02-06) beds in Department of Oncology, Örebro University Hospital.

During the past decade, Department of Oncology, Örebro University Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Oncology, Örebro University Hospital" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Kenny Rodriguez-Wallberg" with 1 trials sponsored, "Lund University Hospital" with 1 trials sponsored, "Nordic Lymphoma Group" with 1 trials sponsored and "Puma Biotechnology, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Oncology, Örebro University Hospital" #1 collaborator was "ATOS" with 1 trials as a collaborator, "Arthur's Legal" with 1 trials as a collaborator, "CareAcross" with 1 trials as a collaborator, "DFKI - German Research Center for Artificial Intelligence" with 1 trials as a collaborator and "Danish Breast Cancer Cooperative Group" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Department of Oncology, Örebro University Hospital" are "Breast Cancer" (2 trials), "Rheumatoid Arthritis" (2 trials), "Acute Leukemia" (1 trials), "Breast Cancer Female" (1 trials) and "DLBCL" (1 trials). Many other conditions were trialed in "Department of Oncology, Örebro University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Oncology, Örebro University Hospital" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASCAPE-based follow-up strategy" (1 trials), "Methotrexate" (1 trials), "Non-Biologic DMARDs" (1 trials), "R-mini-CHOP" (1 trials) and "R-pola-mini-CHP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Oncology, Örebro University Hospital" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Oncology, Örebro University Hospital". 1 are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Department of Oncology, Örebro University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Oncology, Örebro University Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".